Welcome

Sign out Have a question? We're here to help

Sign out

Yaskawa (YASKY)

$74.32 1.87 (2.45%)

15:51 EDT YASKY Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 9.83B

PE Ratio -

EPS -

Volume (Avg. Vol.) 3,300

Day's Range 73.36 - 74.32

52-Week Range 41.63 - 81.22

Dividend & Yield N/A (N/A)

YASKY Stock Predictions, Articles, and Yaskawa News

From InvestorPlace
From the Web

20 Automation Stocks for the Revolution in Robotics

By Josh Enomoto, InvestorPlace Contributor Jul 27, 2018

Automation stocks have been soft so far in 2018, but savvy investors see a chance to buy in on a megatrend at a major discount.

What Kind Of Shareholders Hold The Majority In CymaBay Therapeutics, Inc.’s (NASDAQ:CBAY) Shares?

From Simply Wall St Jul 3, 2020

The big shareholder groups in CymaBay Therapeutics, Inc. (NASDAQ:CBAY) have power over the company. Institutions often own shares in more established companies, while it’s not unusual to see insiders own<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cbay/cymabay-therapeutics/news/what-kind-of-shareholders-hold-the-majority-in-cymabay-therapeutics-inc-s-nasdaqcbay-shares/">Read More...</a></div>

CymaBay Therapeutics files for $200M mixed shelf (NASDAQ:CBAY)

From Seeking Alpha Jul 2, 2020

CymaBay Therapeutics (NASDAQ:CBAY) has filed a prospectus for a $200M mixed shelf offering.

Inventiva files for IPO (NASDAQ:GNFT)

From Seeking Alpha Jun 19, 2020

Fresh off positive results from a mid-stage study evaluating its lead drug in nonalcoholic steatohepatitis (NASH), French biotech Inventiva S.A. (IVA) has filed a preliminary prospectus for a

Noteworthy Friday Option Activity: CBAY, STNG, HLF

From Market News Video Jun 19, 2020

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in CymaBay Therapeutics Inc (CBAY), where a total volume of 12,201 contracts has been traded thus far today, a contract volume which is representative of approximately 1.2 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 72.7% of CBAY's average daily trading volume over the past month, of 1.7 million shares..

CymaBay up 7% on new seladelpar data in bile duct disorder (NASDAQ:CBAY)

From Seeking Alpha Jun 19, 2020

CymaBay Therapeutics (CBAY +7.1%) perks up, albeit on below-average volume, on the heels of new data from a previously completed open-label Phase 2 clinical trial evaluating seladelpar in patients wit

Is the Options Market Predicting a Spike in CymaBay (CBAY) Stock?

From Zacks Investment Research Jun 18, 2020

Investors need to pay close attention to CymaBay (CBAY) stock based on the movements in the options market lately.

Premium Services

We are always here to help!

Not Yet a Subscriber?

Welcome

Welcome

Yaskawa (YASKY)

Premium Services

We are always here to help!

Not Yet a Subscriber?

Welcome

Already a subscriber?

Welcome

Yaskawa (YASKY)

YASKY Stock Predictions, Articles, and Yaskawa News

20 Automation Stocks for the Revolution in Robotics

What Kind Of Shareholders Hold The Majority In CymaBay Therapeutics, Inc.’s (NASDAQ:CBAY) Shares?

CymaBay Therapeutics files for $200M mixed shelf (NASDAQ:CBAY)

Inventiva files for IPO (NASDAQ:GNFT)

Noteworthy Friday Option Activity: CBAY, STNG, HLF

CymaBay up 7% on new seladelpar data in bile duct disorder (NASDAQ:CBAY)

Is the Options Market Predicting a Spike in CymaBay (CBAY) Stock?

Subscriber Sign in